课题基金 / 基金详情

A novel therapeutic strategy for treatment of diabetic skin ulcer using phosphoenolpyruvic acid

A novel therapeutic strategy for treatment of diabetic skin ulcer using phosphoenolpyruvic acid
使用磷酸烯醇丙酮酸治疗糖尿病皮肤溃疡的新治疗策略
批准号:
17590472
负责人:
IRIE Tetsumi
金额:
$2.3万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2005
资助国家:
日本
项目状态:
已结题
起止时间:
2005 至 2006

项目摘要

项目成果

IRIE Tetsumi的其他基金

相关文献

中文摘要
翻译
磷酸烯醇式丙酮酸(PEP)是一种糖酵解中间体,具有高能的磷酸键,能够穿透细胞胞膜。本研究的目的是考察PEP在体外和体内条件下对难治性糖尿病皮肤溃疡愈合过程的影响。结果表明:1)在遗传性糖尿病小鼠创面喷洒3%PEP水溶液后,创面再上皮化、新生血管和肉芽组织形成时间较早。外用PEP的疗效几乎等于或高于市售的碱性成纤维细胞生长因子外用制剂。2)PEP可促进小鼠巨噬细胞样细胞系RAW264产生促进伤口愈合的重要因子--血管内皮生长因子。另外,PEP的代谢产物丙酮酸对人真皮成纤维细胞TIG109细胞的增殖无影响。4)PEP促进人脐静脉内皮细胞的增殖、迁移和管状形成,同时促进血管内皮生长因子和碱性成纤维细胞生长因子的产生。5)PEP促进人角质形成细胞系HaCaT的增殖。这些结果表明,细胞激活剂PEP可能通过促进血管内皮细胞、巨噬细胞和角质形成细胞的细胞增殖和产生生长因子来促进伤口愈合,这些细胞在愈合过程中发挥着重要作用。我们认为PEP可能是治疗顽固性糖尿病皮肤溃疡的一种有前途的候选药物。
英文摘要
Phosphoenolpyruvic acid (PEP), a glycolytic intermediate, has a high energy phosphate bond, and is capable of penetrating through the cel1 membrane. The aim of this research is to examine the effect of PEP on the healing process of intractable diabetic skin ulcer under in-vitro and in-vivo conditions. We obtained the following results:1) When PEP n 3% aqueous solution was sprayed onto the skin wounds of genetically diabetic mice, PEP showed earlier healing with re-epithelialization, neovasculalization and granulation tissue formation. The efficacy of PEP sprayed topically was almost equal to or more effective than that of the commercially available topical preparation of basic fibroblast growth factor.2) The production of vascular endothelial growth factor (VEGF), an important factor for wound healing, from mouse macrophage-like cell line RAW264 was increased in the presence of PEP. In addition, a metabolite of PEP, pyruvic acid facilitated the production.3) On the other hand, PEP did not affect the cell proliferation in TIG109 cells, derived from human dermal fibroblast.4) PEP facilitated the proliferation, migration and tube formation of human umbilical vein endothelial cells, and simultaneously increased the production of VEGF and bFGF. The tube formation by PEP was inhibited by co-incubation with VEGF neutralized antibody.5) PEP increased the proliferation of human keratinocyte cell line HaCaT.These results indicate that a cell activating agent PEP potentially promotes wound healing through the cell proliferation and the production of growth factors in vascular endothelial cells, macrophages and keratinocytes, the cells of which play an important role n the healing. We suggest that PEP can be a promising candidate for the treatment of intractable diabetic skin ulcer.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Cyclodextrins as Modifiers of Intracellular Cholesterol Trafficking in Niemann-Pick Disease Type C
  • 批准号:
    23590642
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $3.33万
  • 财政年份:
    2011
  • 负责人:
    IRIE Tetsumi
  • 依托单位:
Aminophylline induced-neuronal cell injury under hypoxic conditions and the survey of the protective agents against the injury.
  • 批准号:
    20590540
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $2.5万
  • 财政年份:
    2008
  • 负责人:
    IRIE Tetsumi
  • 依托单位:
Accelerated Ulcer Healing via Activation of Endogenous Tissue Repairing Factors by Sulfated Cyclic Oligosaccharides
  • 批准号:
    08672563
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $1.41万
  • 财政年份:
    1996
  • 负责人:
    IRIE Tetsumi
  • 依托单位:
Design of Cyclodextrin Derivatives as Artificial Lipid Carriers that are not Receptor-directed
  • 批准号:
    05671873
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)
  • 资助金额:
    $1.34万
  • 财政年份:
    1993
  • 负责人:
    IRIE Tetsumi
  • 依托单位: